Stock News
Unveiling the Success Story of International Money Express Inc: A Comprehensive Recap of Q3 2024 Earnings Call
International Money Express, Inc. (NASDAQ:IMXI) Q3 2024 Earnings Conference Call Overview Company Participants: Alex Sadowski – Investor Relations Bob Lisy – Chairman, President and CEO Andras Bende – Chief Financial Officer Marcelo Theodoro – Head, Chief Digital and Product Good day and thank you for standing by. Welcome to the International Money Express Third Quarter…
Get the Scoop on Nippon Telegraph and Telephone Corporation’s Q2 2025 Earnings Call: A Playful and Relatable Recap!
Welcome to the NTT Corporation Earnings Conference Call! Meet the Key Players During this quarter’s earnings call, we have some key players joining us: Takuro Hanaki – Head of Investor Relations Akira Shimada – Representative Member of the Board, President and CEO Takashi Hiroi – Representative Member of the Board and Senior Executive Vice President…
Extendicare Unveils New $275 Million Senior Secured Credit Facility for Enhanced Senior Care Services
Extendicare Inc. Enters Into New Senior Secured Credit Facility MARKHAM, Ontario, Nov. 08, 2024 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it has secured a new senior secured credit facility for $275.0 million with a syndicate of Canadian chartered banks. The facility, which has a term of three…
APYX Medical Corporation’s Q3 2024 Earnings Call: A Comprehensive Recap
Apyx Medical Corporation (NASDAQ:APYX) Q3 2024 Earnings Call Transcript Analysis Introduction Welcome to the Apyx Medical Third Quarter 2024 Earnings Conference Call. In this transcript, we will analyze the key highlights from the call with company executives and industry analysts. The call took place on November 8, 2024, at 8:00 AM ET. Key Participants The…
Cue Biopharma Shares Promising Results from Phase 1 Trials of CUE-101 and CUE-102 for Head and Neck Cancer and WT1-Positive Cancers at SITC 39th Annual Meeting
CUE Biopharma Presents Updated Data on CUE-101 at SITC 2024 Introduction BOSTON, Nov. 08, 2024 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of cancer and autoimmune disease, today presented updated data from…
Clever, Personable, and Unconventional: DoubleVerify to Take Part in Upcoming Investor Conferences
Clever, Personable, and Unconventional – Mark Zagorski at Investor Conferences DoubleVerify (“DV”) CEO, Mark Zagorski, is set to participate in two upcoming investor conferences, showcasing the company’s innovative software platform for digital media measurement, data, and analytics. The events, Truist Securities Virtual Internet Growth Summit and 2024 RBC Global TIMT Conference, are scheduled for November…
Revolutionizing Breast Cancer Treatment: Anixa Biosciences and Cleveland Clinic Unveil Promising Results from Phase 1 Study at SITC Annual Meeting
Data continues positive trend as additional patients are enrolled in 3 cohorts Vaccine was safe and well tolerated by participants in all 3 cohorts Protocol defined immune responses were exhibited in over 70% of patients A Phase 2 study evaluating the vaccine in the neoadjuvant setting is planned to commence in 2025 SAN JOSE, Calif.,…
Maximizing Value: A Look into Share Transactions in 2024
Transaction in Own Shares 08 November, 2024 Shell plc Announces Share Purchase Details Shell plc (the ‘Company’) announces that on 08 November 2024 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase | Number of Shares purchased | Highest price paid | Lowest…